Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
about
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitroAntimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsA functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation.Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid.Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsRespiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidantsElafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosisTrappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitmentProteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.Antiproteases as therapeutics to target inflammation in cystic fibrosis.Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells.Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media.Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis.α1-antitrypsin production by proinflammatory and antiinflammatory macrophages and dendritic cells.Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes.Cervical Expression of Elafin and SLPI in Pregnancy and Their Association With Preterm Labor.
P2860
Q24799057-BD589604-17A7-4E73-BA61-A31FE873B0B2Q28087327-D4644802-A8E4-41C4-AFE6-2CB8551791EBQ35591399-DE18565D-3C72-4D48-9878-0A2FFBE5ACA3Q35671345-064321A4-E768-4FAB-B6B9-65378B001FD4Q35868058-DBBD2754-4387-41BE-923E-50EA651F3E20Q36104532-FC9EB49E-64CF-4A29-978F-E62C47860DB1Q36973716-D35A4FE1-8F94-4067-963F-15F711EB265CQ37164539-10D68643-CC57-48C7-9C58-6EDDEA079CAAQ37447482-0A1A6AB9-70D6-4BBE-8FB3-741AD29DFC10Q40363808-E91680E3-A9DB-4166-AE3A-E0C8773C8690Q40882951-66AADD38-67F3-4383-BD0B-C19BA63F992DQ41886610-13A25F19-973B-45BD-8631-B69E94CC31E5Q43554883-D05647BD-B124-4FA5-8A99-1573FF3891DDQ43741467-C5C6A732-6C50-46D8-BDC3-3DA1656E58D8Q47675233-FE3851B1-CF61-473A-8F5F-EEDE2A3B2949Q53652965-4EA39C2C-F571-4AF9-8D36-32D16A926B23
P2860
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@ast
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@en
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@nl
type
label
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@ast
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@en
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@nl
prefLabel
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@ast
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@en
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@nl
P356
P1476
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor
@en
P2093
G M Tremblay
P356
10.1515/ZNC-2001-3-420
P407
P577
2001-01-01T00:00:00Z